Efficacy of Ultralow-Dose Valganciclovir Chemoprophylaxis for Cytomegalovirus Infection in ABO-Incompatible Kidney Transplantation Recipients.

J H Lee,S D Hwang,J H Song,J H Kim,H Y Kim,D Y Lee, J S Oh, Y H Sin,J K Kim

Transplantation Proceedings（2018）

引用 5|浏览8

暂无评分

摘要

•Ultralow-dose VGCV (450 mg) was administered to ABOiKTP recipients for preventing CMV infection.•CMV infection did not occur in any patient receiving ultralow-dose VGCV.•Ultralow-dose VGCV was effective.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要